Posted by Michael Wonder on 23 May 2023
Health Canada’s position on the CADTH guidance for reporting RWE to support decision-making
18 May 2023 - Canada’s CADTH collaborated with Health Canada and other stakeholders to develop the guidance for reporting real world evidence to support decision-making.
This guidance promotes the use of high quality real world data and real world evidence in drug development and regulatory decision-making. It also emphasises the importance of transparent and comprehensive reporting of real world evidence studies to assess reliability and reproducibility.
